The aim of the study was to evaluate the diagnostic value of PIVKA-II and AFP in the diagnosis of HBV-related HCC and futher analysis the level of AFP and PIVKA-II in HBV-related HCC patients with different clinicopathologic characteristics such as tumor differentiation and vascular invasion. Here, AFP is linked to hepatocellular carcinoma.